Lord's Mark Industries Receives ₹48.5 Crore Share Purchase Offer, Declines Due to Ongoing Listing Process
Lord's Mark Industries Limited received an Expression of Interest from JaiBharti Capital Advisory Private Limited to purchase 5,00,000 equity shares at ₹97 per share, representing a transaction value of approximately ₹48.5 crores. The offer was based on a professional valuation that assessed the company's total worth at ₹4,136.45 crores as of December 31, 2025. However, the company declined the proposal, stating that its equity shares' trading and listing process is currently underway, preventing any share transfer transactions at this time.

*this image is generated using AI for illustrative purposes only.
Lord's Mark Industries Limited has informed the BSE about receiving and declining a significant share purchase proposal from JaiBharti Capital Advisory Private Limited. The company received the Expression of Interest on February 05, 2026, but has chosen not to proceed due to its ongoing listing process.
Transaction Details
The proposed transaction involved substantial financial commitments and was backed by professional valuation analysis:
| Parameter: | Details |
|---|---|
| Interested Party: | JaiBharti Capital Advisory Private Limited |
| Proposed Purchase: | 5,00,000 equity shares |
| Offered Price: | ₹97 per equity share |
| Total Transaction Value: | ₹48.5 crores (approximately) |
| Valuation Date: | December 31, 2025 |
| Valuation Report Date: | January 09, 2026 |
Company Valuation Assessment
The offer price was determined based on a comprehensive valuation report prepared by registered valuer Nitish Chaturvedi. The valuation employed the Discounted Cash Flow (DCF) method across the company's three main business divisions:
| Business Division: | Valuation (₹ Crores) |
|---|---|
| LED/Solar Division: | 1,470.45 |
| Paper Division: | 539.86 |
| Pharmaceutical Division: | 2,000.86 |
| Total Company Valuation: | ₹4,136.45 crores |
| Fair Value per Share: | ₹97 |
The valuation considered the company's diversified operations spanning paper manufacturing, renewable energy solutions, and healthcare products. The pharmaceutical division represented the largest component of the company's assessed value, reflecting strong growth projections in the healthcare sector.
Company's Response and Current Status
Lord's Mark Industries, through its Managing Director Sachidanand Hariram Upadhyay, formally responded to JaiBharti Capital Advisory on February 05, 2026. The company explained that since the trading and listing of its equity shares is currently under process, it cannot consider or proceed with any transactions involving purchase or transfer of equity shares at this stage.
The company emphasized that no transaction has been undertaken and there is no impact on the shareholding pattern, management, or control of the company. This decision aligns with regulatory requirements and standard practices during listing processes.
Business Operations Overview
Lord's Mark Industries operates through three primary divisions. The Paper Division manufactures computer continuous paper stationery and copier papers under the "SAPPHIRE" brand, serving major clients including Indian Railways, postal departments, and government institutions. The LED-Solar Division focuses on renewable energy solutions, including solar street lights and LED lighting systems, with partnerships under government schemes like SAUBHAGYA.
The Healthcare & Pharmaceutical Division operates under the "LordsMed" brand, offering diagnostic products, rapid test kits with ICMR approval, and surgical products. The division also holds an exclusive license from IIT Bombay for specialized technology with significant market potential.
Regulatory Compliance
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided all necessary documentation to the BSE, including the original Expression of Interest, the company's response letter, and the detailed valuation report.
The company's decision to decline the offer demonstrates adherence to regulatory protocols during the listing process, ensuring transparency and compliance with securities market regulations.
Source: BSE Filing






























